drugset / Trial / NCT00353808
A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain.
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the long-term safety and tolerability of \[S,S\]-Reboxetine in patients with chronic pain following shingles. This is the extension study of Protocol A6061026.
Timeline
- Start
- 2006-07
- Primary completion
- —
- Completion
- 2007-10
Outcome
Outcome not reported
Stopped: “This study has been terminated early as the esreboxetine development program is being discontinued. There are no safety or efficacy concerns.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [S,S]-Reboxetine | Unknown | — | — |
Indications
No indication recorded.